Assignee
LIN SHI-LUNG
US·13 granted patents·13 pending applications·17 citations·filing 2003–2024
Top patents by PatentIndex Score
26 records- 0184US9399773B2Production and extraction of MicroRNA precursor as drug for cancer therapyLIN SHI-LUNG·Filed 2013·Granted Jul 26, 2016·5 cites·13 claims
- 0281US9387251B2Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitroLIN SHI-LUNG·Filed 2014·Granted Jul 12, 2016·3 cites·30 claims
- 0379US8609831B2RNA-mediated gene modulationLIN SHI-LUNG·Filed 2003·Granted Dec 17, 2013·5 cites·12 claims
- 0472US9422559B2Production and utilization of a novel anti-cancer drug in therapyLIN SHI-LUNG·Filed 2013·Granted Aug 23, 2016·1 cites·9 claims
- 0571US9567591B2Generation of human embryonic stem-like cells using intronic RNALIN SHI-LUNG·Filed 2008·Granted Feb 14, 2017·1 cites·32 claims
- 0671US9453219B2Cosmetic designs and products using intronic RNALIN SHI-LUNG·Filed 2007·Granted Sep 27, 2016·1 cites·11 claims
- 0771US2025019709A1Novel oxo-rna compositions and the related applications thereofLIN SHI LUNG·Filed 2024·Application pending·0 cites
- 0868US2025115932A1Induced cytoplasmic ivt (icivt)-like composition and the related vaccine medicine designs thereofLIN SHI LUNG·Filed 2023·Application pending·0 cites
- 0967US9956196B2Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugsLIN SHI LUNG·Filed 2014·Granted May 1, 2018·0 cites·12 claims
- 1067US2024093286A1Novel Replicase Cycling Reaction (RCR) and the Related RdRP-Binding Site Designs ThereofLIN SHI LUNG·Filed 2023·Application pending·0 cites
- 1166US2023295627A1Novel Replicase Cycling Reaction (RCR) and the Related SamRNA Designs ThereofLIN SHI LUNG·Filed 2023·Application pending·0 cites
- 1265US9394538B2Development of universal cancer drugs and vaccinesLIN SHI-LUNG·Filed 2010·Granted Jul 19, 2016·1 cites·27 claims
- 1363US2023099592A1Novel replicase cycling reaction (rcr)LIN SHI LUNG·Filed 2022·Application pending·0 cites
- 1462US12590329B2Replicase cycling reaction (RCR)LIN SHI LUNG·Filed 2022·Granted Mar 31, 2026·0 cites·18 claims
- 1559US2022396778A1Novel RNA Composition and Production Method for Use in iPS Cell GenerationLIN SHI LUNG·Filed 2022·Application pending·0 cites
- 1656US10370658B2Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancerLIN SHI LUNG·Filed 2017·Granted Aug 6, 2019·0 cites·20 claims
- 1754US9907773B2Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugsLIN SHI LUNG·Filed 2016·Granted Mar 6, 2018·0 cites·15 claims
- 1854US2020165607A1Composition and method of using mir-302 precursors as anti-cancer drugs for treating human lung cancerLIN SHI LUNG·Filed 2019·Application pending·0 cites
- 1953US2013210120A1Inducible Gene Expression Composition for Using Eukaryotic Pol-2 Promoter-Driven Transcription in Prokaryotes and the Applications ThereofLIN SHI-LUNG·Filed 2012·Application pending·0 cites
- 2051US2017342418A1Use of microrna precursors as drugs for inducing cd34-positive adult stem cell expansionLIN SHI-LUNG·Filed 2017·Application pending·0 cites
- 2150US12570977B2mRNA composition and production method for use in anti-viral and anti-cancer vaccinesLIN SHI LUNG·Filed 2021·Granted Mar 10, 2026·0 cites·15 claims
- 2250US2009203141A1Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agentsLIN SHI-LUNG·Filed 2009·Application pending·0 cites
- 2348US11624067B2In-vitro induction of adult stem cell expansion and derivationLIN SHI LUNG·Filed 2018·Granted Apr 11, 2023·0 cites·16 claims
- 2445US2006228800A1Novel Transgenic Methods Using intronic RNALIN SHI-LUNG·Filed 2006·Application pending·0 cites
- 2538US2016289682A1Production and utilization of a novel anti-cancer drug in therapyLIN SHI-LUNG·Filed 2016·Application pending·0 cites
- 2632US2020318110A1A composition and method of using mir-302 precursors as anti-cancer drugs for treating human lung cancerLIN SHI LUNG·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →